> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# UnitedHealth sells TPG a stake in the Florida clinics that broke its 2025 earnings
- URL: https://members.americanhealthintel.com/2026-09-11-ledger/
- Published: 2026-09-11T15:57:53.000Z
- Updated: 2026-09-11T15:57:53.000Z
- Description: Plus: Elevance surges, UnitedHealth stumbles, at the same investor conference. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: Elevance surges, UnitedHealth stumbles, at the same investor conference. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Ledger Friday, September 11, 2026 UnitedHealth sells TPG a stake in the Florida clinics that broke its 2025 earnings Plus: Elevance surges, UnitedHealth stumbles, at the same investor conference. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Deal Confidence: Medium UnitedHealth Group, the parent of insurer UnitedHealthcare and care-delivery arm Optum, just sold a stake in the exact Florida clinic business whose cost overruns wrecked its 2025 earnings. Private equity firm TPG bought the interest in Optum Health's WellMed clinics, disclosed Sept 8\. UnitedHealth's CFO says it's about local operating focus, not capital. Shares fell 3% on the news. Why it matters UnitedHealth brought in a private equity partner for the exact Florida clinic business that hurt its earnings last year, and investors read that as a mixed signal about how fixed the turnaround really is. Sources: [Bloomberg](https://www.bloomberg.com/news/articles/2026-09-09/unitedhealth-sells-interest-in-florida-wellmed-clinics-to-tpg?ref=members.americanhealthintel.com) · [247wallst](https://247wallst.com/investing/2026/09/09/unitedhealth-slips-3-as-tpg-buys-into-florida-wellmed-clinics-ahead-of-guidance-reaffirmation/?ref=members.americanhealthintel.com) · [Co](https://www.privateequitywire.co.uk/tpg-takes-stake-in-unitedhealths-florida-wellmed-clinics/?ref=members.americanhealthintel.com) Other Confidence: Medium Two of the country's biggest health insurers left the same investor conference this week with opposite stock reactions, and it wasn't about Medicare Advantage this time. Elevance Health's CFO said Sept 10 that Q3 earnings are tracking ahead of plan; shares rose about 5%. UnitedHealth fell 3% days earlier on separate news, even as both companies reaffirmed guidance. Why it matters Two big insurers gave similar reassurances at the same investor conference this week and got opposite stock reactions, a sign investors are judging turnaround credibility as much as the numbers. Sources: [Investing](https://ca.investing.com/news/stock-market-news/elevance-health-at-wells-fargo-conference-growth-plan-stays-on-track-93CH-4834789?ref=members.americanhealthintel.com) · [Gurufocus](https://www.gurufocus.com/news/3158261/elevance-health-inc-at-wells-fargo-healthcare-conference-transcript?ref=members.americanhealthintel.com) · [Optionstradingreport](https://www.optionstradingreport.com/2026/09/elevance-surges-5-on-strong-q3-signal-as-unitedhealth-falls-3/?ref=members.americanhealthintel.com) Also today Norman Regional Health System's bond trouble becomes an actual default [Read](https://americanhealthintel.com/editions/2026-09-11-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#norman-regional-bond-default-avoidance) Definitive Healthcare clears legal hurdle to Advent going-private deal [Read](https://americanhealthintel.com/editions/2026-09-11-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#definitive-healthcare-advent-going-private-tra-waiver) Axogen pays $200M for BioCircuit's sutureless nerve-repair device [Read](https://americanhealthintel.com/editions/2026-09-11-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#axogen-biocircuit-nervetape-acquisition) 709Records$38.5BEnforcement32Deadlines186Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-09-11-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |